Reports from Phase III Trials of CHOP-Containing Regimens for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)


Reports from Phase III Trials of CHOP-Containing Regimens for the Treatment of Diffuse Large B-Cell Lymphoma (DLBCL)
Slides from presentations at ASCO 2011 and comments from John P Leonard, MD

Stiff PJ et al. Randomized Phase III US/Canadian Intergroup trial (SWOG S9704) comparing CHOP±R x 8 vs CHOP±R x 6 followed by high dose therapy and auto transplant for patients with diffuse aggressive non-Hodgkin's lymphoma (NHL) in high-intermediate (H-Int) or high IPI risk groups. Proc ASCO 2011;Abstract 8001.

Dr Leonard is the Richard T Silver Distinguished Professor of Hematology and Medical Oncology and Professor of Medicine at Weill Cornell Medical College in New York, New York.